DHEA — Stack & Timing
Educational timing and stacking information based on how DHEA has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how DHEA has been studied and commonly used.
Commonly studied timing
DHEA is typically recommended in the morning to mimic the body's natural diurnal cortisol and DHEA secretion pattern, which peaks in the early hours. Taking it with food may improve tolerability and absorption, consistent with general fat-soluble hormone precursor guidance.
Dose ranges used in studies
Expert clinicians such as Peter Attia suggest trialing 25–50 mg/day in adults over 50 with confirmed low DHEA-S levels; some reviews and RCTs have used doses ranging from 25 mg up to 100 mg depending on the outcome studied (bone density, mood, adrenal support), but individual needs vary and baseline lab testing is strongly advised before supplementing.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Both are involved in hormonal and immune regulation; Vitamin D deficiency is common in populations with low DHEA, and they may have complementary roles in aging-related decline.
Ashwagandha has been shown in RCTs to reduce cortisol and support adrenal function; since chronic stress suppresses DHEA production, combining an adaptogen may help restore the cortisol-to-DHEA balance.
Vitamin C has been shown in RCTs to reduce hypercortisolemia from chronic stress; since elevated cortisol suppresses DHEA, Vitamin C may support a more favorable DHEA-to-cortisol ratio.
Magnesium supports HPA axis regulation and stress resilience; it is often co-supplemented with adrenal-support protocols that include DHEA.
Safety & interactions
DHEA is a hormone precursor that can convert to androgens and estrogens; unsupervised use carries risks of hormonal imbalance, acne, hair loss, and in women, virilization. Long-term safety data are limited, and use should ideally be guided by baseline and follow-up DHEA-S lab measurements. The 7-keto-DHEA form does not convert to sex hormones and may have a different safety profile.
- •May interact with hormone-sensitive medications including estrogen and testosterone therapies
- •May affect insulin sensitivity and interact with antidiabetic medications
- •Potential interaction with corticosteroids due to shared adrenal pathways
- •May influence anticoagulant activity — caution with blood thinners
Individuals with hormone-sensitive conditions (e.g., breast, ovarian, uterine, or prostate cancer) should avoid DHEA. Those with polycystic ovary syndrome (PCOS), liver disease, or a history of hormone-dependent tumors should use caution. Not recommended during pregnancy or breastfeeding. Use in individuals under 40 without confirmed deficiency is generally not supported.